• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

Acadia Pharmaceuticals Inc. (ACAD) - Financial and Strategic SWOT Analysis Review

  • ID: 1322588
  • May 2015
  • 50 pages
  • GlobalData

FEATURED COMPANIES

  • Allergan, Inc.
  • Pfizer Inc.
  • Targacept, Inc.
  • MORE

Acadia Pharmaceuticals Inc. (ACAD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by The publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of READ MORE >

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Allergan, Inc.
  • Pfizer Inc.
  • Targacept, Inc.
  • MORE

List of Tables
List of Figures
Section 1 - About the Company
Acadia Pharmaceuticals Inc. - Key Facts
Acadia Pharmaceuticals Inc. - Key Employees
Acadia Pharmaceuticals Inc. - Key Employee Biographies
Acadia Pharmaceuticals Inc. - Major Products and Services
Acadia Pharmaceuticals Inc. - Pharmaceutical Pipeline Products Data
Acadia Pharmaceuticals Inc., Pipeline Products by Therapy Area
Acadia Pharmaceuticals Inc., Pipeline Products by Development Phase
Acadia Pharmaceuticals Inc. - History
Acadia Pharmaceuticals Inc. - Company Statement
Acadia Pharmaceuticals Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 - Company Analysis
Acadia Pharmaceuticals Inc. - Business Description
Acadia Pharmaceuticals Inc. - Corporate Strategy
Acadia Pharmaceuticals Inc. - SWOT Analysis
SWOT Analysis - Overview
Acadia Pharmaceuticals Inc. - Strengths
Strength - Focused Research and Development
Strength - Strong Patent Portfolio
Strength - Lead Product: Nuplazid
Acadia Pharmaceuticals Inc. - Weaknesses
Weakness - Lack of Marketed Products
Acadia Pharmaceuticals Inc. - Opportunities
Opportunity - Changing Demographics
Opportunity - Strong Product Pipeline
Opportunity - Market Potential: Parkinson’s Disease
Acadia Pharmaceuticals Inc. - Threats
Threat - Lack of Manufacturing Facilities
Threat - Uncertain R&D Outcomes
Threat - Stringent Government Regulations
Threat - Intense Competition
Acadia Pharmaceuticals Inc. - Key Competitors
Section 3 - Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
Acadia Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Acadia Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015
Acadia Pharmaceuticals Inc., Recent Deals Summary
Section 5 - Company’s Recent Developments
May 07, 2015: ACADIA Pharmaceuticals Reports First Quarter 2015 Financial Results
Mar 26, 2015: ACADIA Pharmaceuticals Appoints Daniel Soland to Board of Directors
Mar 12, 2015: Harwood Feffer Announces Investigation of Acadia Pharmaceuticals
Mar 11, 2015: ACADIA Pharmaceuticals Announces Retirement of Uli Hacksell, Ph.D., Chief Executive Officer
Feb 26, 2015: ACADIA Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2014
Nov 10, 2014: ACADIA Pharmaceuticals Reports Third Quarter 2014 Financial Results and Updates Timing of NUPLAZID NDA Submission
Aug 05, 2014: Acadia Pharmaceuticals Reports Second Quarter 2014 Financial Results
Jul 15, 2014: ACADIA Pharmaceuticals Announces Appointment of Stephen Davis as Executive Vice President, Chief Financial Officer and Chief Business Officer
May 06, 2014: ACADIA Pharmaceuticals Reports First Quarter 2014 Financial Results
Feb 27, 2014: ACADIA Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2013
Section 6 - Appendix
Methodology
Ratio Definitions
About Us
Contact Us
Disclaimer

List of Tables
Acadia Pharmaceuticals Inc., Key Facts
Acadia Pharmaceuticals Inc., Key Employees
Acadia Pharmaceuticals Inc., Key Employee Biographies
Acadia Pharmaceuticals Inc., Major Products and Services
Acadia Pharmaceuticals Inc., Number of Pipeline Products by Therapy Area
Acadia Pharmaceuticals Inc., Number of Pipeline Products by Development Stage
Acadia Pharmaceuticals Inc., Pipeline Products By Therapy Area and Development Phase
Acadia Pharmaceuticals Inc., History
Acadia Pharmaceuticals Inc., Subsidiaries
Acadia Pharmaceuticals Inc., Key Competitors
Acadia Pharmaceuticals Inc., Ratios based on current share price
Acadia Pharmaceuticals Inc., Annual Ratios
Acadia Pharmaceuticals Inc., Interim Ratios
Acadia Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Acadia Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015
Acadia Pharmaceuticals Inc., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Acadia Pharmaceuticals Inc., Pipeline Products by Therapy Area
Acadia Pharmaceuticals Inc., Pipeline Products by Development Phase
Acadia Pharmaceuticals Inc., Performance Chart (2010 - 2014)
Acadia Pharmaceuticals Inc., Ratio Charts
Acadia Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Acadia Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015

Note: Product cover images may vary from those shown

Alseres Pharmaceuticals, Inc.
Targacept, Inc.
Vanda Pharmaceuticals Inc.
Allergan, Inc.
Pfizer Inc.

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Grifols, S.A. Takeda Pharmaceutical Company Limited Alexion Pharmaceuticals Teva Pharmaceutical Industries Ltd. Endo International Plc. Essilor International S.A.